Latest tumor Stories
Interim analysis of the pivotal phase III trial of Tumor Treating Fields in newly diagnosed glioblastoma (EF-14) will be presented as a late-breaking oral presentation ST.
Results presented in poster presentation beginning today and in oral presentation Saturday, November 8, at 1:40 PM at Society for Immunotherapy of Cancer annual meeting. ANN ARBOR,
Presentations at 2014 Chicago Multidisciplinary Symposium on Thoracic Oncology Point to Potential Strategies for Treatment of Small Cell, Non-small Cell, and Neuroendocrine Lung Cancers
LOS ANGELES, Oct.
Six new members elected at ABTA annual meeting Chicago, IL (PRWEB) October 22, 2014 The American Brain Tumor Association (ABTA) – the first and now
Trial Has Not Yet Reached Necessary Number of Survival Events to Report on Overall Survival Due to Longer than Expected Survival of Study Patients LOS ANGELES, Oct.
Combines NGS and FISH Testing for Comprehensive Cancer Profiling FT. MYERS, Fla., Oct. 16, 2014 /PRNewswire/ -- NeoGenomics, Inc.
Market Size - $174.14 billion in 2013, Market Growth - CAGR of 6.0%, Market Trends - Growing demand for early disease diagnosis - Latest report by Grand View Research.
TUBINGEN, Germany, October 14, 2014 /PRNewswire/ -- Regulatory authority approves clinical trial for Glioma Actively Personalized
Preclinical Data Indicates Targeting Hyaluronan in the Tumor Stroma May Offer A New Approach to Pancreatic Cancer Treatment SAN DIEGO, Oct.
- A hairdresser.